(Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide

C60H115NO4 — CID 138263493

IUPAC(Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide
SMILESCCCCCCCCC/C=C/CC/C=C/CCCC(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCCCC/C=C\CCCCCCCCCCCCCCCC
InChIInChI=1S/C60H115NO4/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-41-43-45-47-49-51-53-55-59(64)61-57(56-62)60(65)58(63)54-52-50-48-46-44-42-40-20-18-16-14-12-10-8-6-4-2/h20,27-28,40,46,48,57-58,60,62-63,65H,3-19,21-26,29-39,41-45,47,49-56H2,1-2H3,(H,61,64)/b28-27-,40-20+,48-46+
InChIKeySQABJORKRAUEKO-KUWYVQFUSA-N
MW914.58 g/mol
LogP18.23
Rot. Bonds54

About (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide

(Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide (PubChem CID 138263493) has the molecular formula C60H115NO4 and a molecular weight of 914.58 g/mol. Its IUPAC name is (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide.

Molecular Properties

Compound Name(Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide
PubChem CID138263493
Molecular FormulaC60H115NO4
Molecular Weight914.58 g/mol
Exact Mass913.88
IUPAC Name(Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide
SMILESCCCCCCCCC/C=C/CC/C=C/CCCC(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCCCC/C=C\CCCCCCCCCCCCCCCC
InChIInChI=1S/C60H115NO4/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-41-43-45-47-49-51-53-55-59(64)61-57(56-62)60(65)58(63)54-52-50-48-46-44-42-40-20-18-16-14-12-10-8-6-4-2/h20,27-28,40,46,48,57-58,60,62-63,65H,3-19,21-26,29-39,41-45,47,49-56H2,1-2H3,(H,61,64)/b28-27-,40-20+,48-46+
InChIKeySQABJORKRAUEKO-KUWYVQFUSA-N
XLogP18.23
TPSA89.79 Ų
H-Bond Donors4
H-Bond Acceptors4
Rotatable Bonds54
Heavy Atoms65
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500914.58
LogP ≤ 518.23
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide?
The IUPAC name of (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide (CID 138263493) is (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide.
What is the SMILES notation for (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide?
The canonical SMILES for (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide is CCCCCCCCC/C=C/CC/C=C/CCCC(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCCCC/C=C\CCCCCCCCCCCCCCCC.
What is the InChIKey of (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide?
The InChIKey is SQABJORKRAUEKO-KUWYVQFUSA-N. The full InChI is InChI=1S/C60H115NO4/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-41-43-45-47-49-51-53-55-59(64)61-57(56-62)60(65)58(63)54-52-50-48-46-44-42-40-20-18-16-14-12-10-8-6-4-2/h20,27-28,40,46,48,57-58,60,62-63,65H,3-19,21-26,29-39,41-45,47,49-56H2,1-2H3,(H,61,64)/b28-27-,40-20+,48-46+.
What are the key properties of (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide?
(Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide has a molecular weight of 914.58 g/mol, XLogP of 18.23, 54 rotatable bonds, 4 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (Z)-N-[(8E,12E)-1,3,4-trihydroxydocosa-8,12-dien-2-yl]octatriacont-21-enamide is sourced from PubChem (CID 138263493), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).